Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2024-10-01
2026-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pathogenic Metagenomic Next-generation Sequencing to Optimize the Diagnosis of Decompensated Cirrhosis Infection
NCT06039696
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
NCT07265544
Integrated Diagnostics for Early Diagnosis of Liver Disease
NCT04666402
Radiomics for Diagnosing Liver Diseases and Evaluating Progression
NCT03221049
Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry
NCT05106322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NAS group
In this group, the investigators will detect the number of pathogen in alveolar lavage fluid, blood and peritoneal drainage by using NAS.
NAS, NGS and Laboratory tests
Using three diffrent detection methods and comparing their efficiency
NGS group
In this group, the investigators will detect the number of pathogen in alveolar lavage fluid, blood and peritoneal drainage by using NGS.
NAS, NGS and Laboratory tests
Using three diffrent detection methods and comparing their efficiency
Lab Tests group
In this group, the investigators will detect the number of pathogen in alveolar lavage fluid, blood and peritoneal drainage by using laboratory tests.
NAS, NGS and Laboratory tests
Using three diffrent detection methods and comparing their efficiency
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NAS, NGS and Laboratory tests
Using three diffrent detection methods and comparing their efficiency
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signing informed consent voluntarily
* Possessing ability to comprehend material information
* Participating this study voluntarily
Exclusion Criteria
* Graft loss
* Have undergone a multi-organ transplantion or have had a previous organ transplantation
* Patient died
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shenzhen Third People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lin Zhong, Dr
Role: PRINCIPAL_INVESTIGATOR
Shenzhen Third People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shenzhen Third People's Hospital
Shenzhen, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Cheng H, Sun Y, Yang Q, Deng M, Yu Z, Zhu G, Qu J, Liu L, Yang L, Xia Y. A rapid bacterial pathogen and antimicrobial resistance diagnosis workflow using Oxford nanopore adaptive sequencing method. Brief Bioinform. 2022 Nov 19;23(6):bbac453. doi: 10.1093/bib/bbac453.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022YFC2304700
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
SZSY001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.